7.99
price down icon0.12%   -0.010
after-market Handel nachbörslich: 7.93 -0.06 -0.75%
loading
Schlusskurs vom Vortag:
$8.00
Offen:
$7.96
24-Stunden-Volumen:
873.25K
Relative Volume:
0.66
Marktkapitalisierung:
$1.08B
Einnahmen:
$175.51M
Nettoeinkommen (Verlust:
$-78.02M
KGV:
-15.08
EPS:
-0.53
Netto-Cashflow:
$-34.18M
1W Leistung:
+0.13%
1M Leistung:
-2.68%
6M Leistung:
-8.37%
1J Leistung:
+51.61%
1-Tages-Spanne:
Value
$7.935
$8.06
1-Wochen-Bereich:
Value
$7.77
$8.085
52-Wochen-Spanne:
Value
$5.15
$10.67

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Name
Firmenname
Aurinia Pharmaceuticals Inc
Name
Telefon
250-744-2487
Name
Adresse
#140, 14315 - 118 AVENUE, EDMONTON, BC
Name
Mitarbeiter
300
Name
Twitter
@AuriniaPharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
AUPH's Discussions on Twitter

Vergleichen Sie AUPH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AUPH
Aurinia Pharmaceuticals Inc
7.99 1.08B 175.51M -78.02M -34.18M -0.53
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-11-04 Herabstufung Oppenheimer Outperform → Perform
2022-05-05 Fortgesetzt Cantor Fitzgerald Overweight
2021-12-10 Hochstufung Oppenheimer Perform → Outperform
2021-10-28 Herabstufung Oppenheimer Outperform → Perform
2021-01-25 Bestätigt H.C. Wainwright Buy
2020-11-03 Bestätigt H.C. Wainwright Buy
2020-06-17 Eingeleitet BTIG Research Buy
2020-05-05 Eingeleitet Cowen Outperform
2020-01-10 Eingeleitet Jefferies Buy
2019-12-16 Bestätigt H.C. Wainwright Buy
2018-03-16 Bestätigt Cantor Fitzgerald Overweight
2018-02-08 Eingeleitet RBC Capital Mkts Outperform
2017-10-30 Bestätigt H.C. Wainwright Buy
2017-05-18 Bestätigt H.C. Wainwright Buy
2017-04-11 Eingeleitet Cantor Fitzgerald Overweight
2017-03-22 Bestätigt FBR & Co. Outperform
2016-12-30 Bestätigt H.C. Wainwright Buy
2016-08-17 Bestätigt H.C. Wainwright Buy
2016-06-30 Eingeleitet H.C. Wainwright Buy
2015-05-08 Eingeleitet MLV & Co Buy
Alle ansehen

Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten

pulisher
Jun 03, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AUPH, IRNT and RSKD - ACCESS Newswire

Jun 03, 2025
pulisher
May 31, 2025

Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock? - MSN

May 31, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Sells 14,003 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 31, 2025
pulisher
May 30, 2025

Is The Options Market Predicting A Spike In Aurinia Pharmaceuticals (AUPH) Stock? - Barchart.com

May 30, 2025
pulisher
May 27, 2025

(AUPH) Technical Data - news.stocktradersdaily.com

May 27, 2025
pulisher
May 22, 2025

Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial Results | AUPH Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study - TipRanks

May 22, 2025
pulisher
May 19, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality - simplywall.st

May 19, 2025
pulisher
May 19, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

May 19, 2025
pulisher
May 16, 2025

Aurinia Pharmaceuticals Inc. Just Recorded A 60% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Aurinia Pharmaceuticals Approves New Equity Incentive Plan - TipRanks

May 15, 2025
pulisher
May 15, 2025

Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Transcript : Aurinia Pharmaceuticals Inc.Shareholder/Analyst Call - marketscreener.com

May 15, 2025
pulisher
May 14, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - MSN

May 14, 2025
pulisher
May 14, 2025

Aurinia Pharmaceuticals Financial Update and Strategic Growth Plans - Zenopa

May 14, 2025
pulisher
May 14, 2025

Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Aurinia outlines $250M–$260M 2025 revenue target as LUPKYNIS sales climb 25% and operational efficiency improves - MSN

May 13, 2025
pulisher
May 13, 2025

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 12, 2025
pulisher
May 12, 2025

Document - SEC.gov

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges - TipRanks

May 12, 2025
pulisher
May 12, 2025

Aurinia: Q1 Earnings Snapshot - MySA

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga

May 12, 2025
pulisher
May 12, 2025

Leerink maintains Aurinia stock Outperform with $10 target - Investing.com

May 12, 2025
pulisher
May 12, 2025

Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens - Investing.com India

May 12, 2025
pulisher
May 12, 2025

AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals' Q1 Swings to Profit, Revenue Rises; Reiterates 2025 Revenue Guidance - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Inc. Reiterates Guidance for the Full Year 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results - TipRanks

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - Business Wire

May 12, 2025
pulisher
May 09, 2025

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

May 09, 2025
pulisher
May 06, 2025

How the (AUPH) price action is used to our Advantage - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - BioSpace

May 05, 2025
pulisher
Apr 30, 2025

Glass Lewis Supports Aurinia’s Proposals for 2025 AGM - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

ISS Endorses Aurinia’s Proposals for 2025 Annual Meeting - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - The Globe and Mail

Apr 30, 2025
pulisher
Apr 29, 2025

ISS Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - BioSpace

Apr 29, 2025
pulisher
Apr 29, 2025

Aurinia Pharmaceuticals (AUPH) Gains Support from ISS for Board - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Aurinia Pharmaceuticals Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView

Apr 28, 2025

Finanzdaten der Aurinia Pharmaceuticals Inc-Aktie (AUPH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):